Kaleidoscope logo
Kaleidoscope

Wayfinder accelerates decision-making and streamlines R&D with dashboards
Case study
Michelle Kriner, PhD
Head of Program Development
Chuhern Hwang, PhD
Founder, Head of Drug Discovery
Science
Small molecule, RNA targeting

Outcomes

Centralized project & entity management
Wayfinder now manages all R&D workflows—from high-level project planning to individual experiments—in one place, reducing dependency on scattered tools and improving alignment across teams
Less meetings, faster decisions
Leadership quickly adopted Kaleidoscope’s dashboards, which now serve as a real-time decision-making hub. This has led to a reduction of ~1 day per week spent on meetings and manual data gathering.
Team multiplier
Shared dashboards and a company roadmap empowered team members to go from thinking day to day to thinking weeks and months in advance, and helps each team member internalize company objectives so they can contribute the most impact.

About Wayfinder Biosciences

Wayfinder Biosciences is pioneering RNA-targeting small molecule therapeutics by combining AI/ML with engineered RNA sensors. Their platform enables high-throughput screening of compounds that selectively modulate RNA, unlocking new possibilities for treating oncology, neurodegeneration, and rare diseases.

Challenges

Fragmented project & entity management

Experimental details were scattered across Slack, Benchling, Google Drive, making it difficult to keep leadership and scientists aligned.

Lack of real-time insights for decision-making

Key experimental data wasn’t easily accessible in a structured way, slowing down data-driven decisions.

Limited transparency in compound tracking

Without a centralized system, tracking the status and results of compounds in the pipeline required constant back and forth communication.

Solutions

Wayfinder adopted Kaleidoscope to plan R&D goals from high-level projects down to specific experiments, track progress efficiently, and give leadership the insights they need to make fast, informed decisions while keeping teams aligned. Instead of relying on scattered tools and ad-hoc communication, everything is now structured and accessible in one place.

A major shift has been the role of dashboards in leadership decision-making. Wayfinder’s leadership, particularly their CTO, quickly adopted dashboards as a central part of tracking and decision-making for their drug development pipeline. Without extensive training, they were able to configure and use dashboards out of the box, which became an organic part of their workflow. Dashboards streamline compound tracking and assay results, making it easy for leadership to compare data across multiple dimensions.

“Our dashboards organize data so that each column represents a compound and each row represents an assay. This structure allows us to easily compare results across assays and compounds, helping us quickly identify the most promising candidates and prioritize our efforts.”
Michelle Kriner, Head of Program Development

By making critical data instantly accessible, Kaleidoscope has significantly reduced the number of meetings needed for data review. Leadership no longer has to chase down results or manually compile updates - everything is readily available in real time. That shift has helped Wayfinder move faster without sacrificing alignment.

“We’ve reduced the meetings we have for data review and our CTO doesn’t have to spend as much time tracking down data – now a lot of that can be done in Kaleidoscope. Before Kaleidoscope, we could spend two-hour meetings making a single decision. Now that’s become clearer and easier with the data readily available for you to internalize at your own pace.”
Michelle Kriner, Head of Program Development
“Kaleidoscope dashboards allow for a centralized tracking system of compounds in our pipeline that is transparent to the whole company. This saves substantial time from having to consult coworkers on the status of experiments or on how results from a specific compound have looked.”
Chuhern Hwang, Founder, Head of Drug Discovery

Unlike most tools, Kaleidoscope was designed with both scientists and leadership in mind, bridging a critical gap. Scientists get the structure they need to organize their work, while leadership gains the high-level insights necessary for decision-making.

With Kaleidoscope, Wayfinder eliminated gaps in communication, improved visibility into R&D workflows, and empowered leadership to make faster, more strategic decisions -without losing alignment across teams.

“Before, people were really only thinking one day in advance, planning tomorrow's experiments today. We’ve come a long way to have people thinking more like weeks and months in advance, really internalizing the company roadmap and our larger goals – so that it's easier to contextualize that there's a reason why something needs to be done this week. Helping people have more ownership over their larger goals… which frees up bandwidth for management too.”
Michelle Kriner, Head of Program Development
Kaleidoscope allows the discovery team to make faster and better-informed decisions because they have all the data at their fingertips.
Ewan Taylor
CSO and Co-founder
We needed a better system for tracking our R&D data and progress — Kaleidoscope enables more efficient decision making and communication to key stakeholders.
Geraldine Paulus
Co-founder, VP Operations
Kaleidoscope expertly streamlines our data sharing with CROs, making sure Psivant remains in perfect harmony.
Shivam Patel
Head of Data Science & ML
Powerful, intuitive, well-designed ... lets biotechs spend resources on their actual IP: the assets and biology.
Brian Naughton
Co-founder and CTO
We realized that sharing our data in Kaleidoscope was really attractive to Pharma partners – it showed clarity of progress and that we have clean and organized data to work with.
SVP Business Development
Platform Tx company with multi-asset pipeline
Prior to Kaleidoscope it would take me 4-5 steps per workflow to do what I can now achieve in one step. I’m also able to spend 3x less time each week searching for, collating, and navigating data.
Director of Preclinical Operations
Early stage small molecule therapeutics company
Kaleidoscope provides the ability to align our key partners, and effectively manage our growing portfolio of IP. It saves us 10 or more hours per week.
Marina Crowe
Chief of Staff